Trinity Biotech to Present at Sidoti & Company's Semiannual New York Micro-Cap Conference on January 9, 2012
January 04 2012 - 6:00PM
PR Newswire (US)
DUBLIN, Jan. 4, 2012 /PRNewswire/ -- Trinity Biotech plc
(NasdaqGS: TRIB), a leading developer and manufacturer of
diagnostic products for the point-of-care and clinical laboratory
markets, announced today that the Company will present at the
Sidoti & Company's Semiannual New York Micro-Cap Conference on
Monday, January 9, 2012 at
9:20 a.m. ET. The conference will be
held at the Grand Hyatt New York Hotel in New York City.
About Trinity Biotech plc
Trinity Biotech develops, acquires, manufactures and
markets diagnostic systems, including both reagents and
instrumentation, for the point-of-care and clinical laboratory
segments of the diagnostic market. The products are used to detect
infectious diseases and to quantify the level of Haemoglobin A1c
and other chemistry parameters in serum, plasma and whole blood.
Trinity Biotech sells direct in the
United States, Germany,
France and the U.K. and through a
network of international distributors and strategic partners in
over 75 countries worldwide. For further information please see the
Company's website: www.trinitybiotech.com.
Contact:
|
Trinity
Biotech plc
|
Lytham
Partners LLC
|
|
Kevin
Tansley
|
Joe Diaz,
Joe Dorame & Robert Blum
|
|
(353)-1-2769800
|
602-889-9700
|
|
E-mail:
kevin.tansley@trinitybiotech.com
|
|
SOURCE Trinity Biotech plc
Copyright 2012 PR Newswire
Trinity Biotech (NASDAQ:TRIB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Trinity Biotech (NASDAQ:TRIB)
Historical Stock Chart
From Apr 2023 to Apr 2024